Publications

03 Nov 2015
First Look

November 3, 2015

November 2015 Quarterly Journal of Economics Behavioral Hazard in Health Insurance By: Baicker, Katherine, Sendhil Mullainathan, and Joshua Schwartzstein Abstract—A fundamental implication of standard moral hazard models is overuse of... View Details

Keywords: Sean Silverthorne

15 Mar 2011
First Look

First Look: March 15

tax policy. Teams and Team Effectiveness in Health Services Organizations Authors:Bruce J. Fried, Sharon Topping, and Amy C. Edmondson Publication:In Health Care Management:... View Details

Keywords: Sean Silverthorne

February 2002 (Revised August 2002)
Case

Inhale Therapeutics: Executing and Growing the Business Model

Inhale is about to bring a novel technology to market that uses inhalation to administer drugs that formerly required injection. Inhale must now decide which way to evolve its business model. This will determine the future direction of growth for the company. View Details

Keywords: Business Model; Technological Innovation; Health Care and Treatment; Growth and Development Strategy; Medical Devices and Supplies Industry

Find at Harvard

08 Nov 2024
Op-Ed

How Private Investors Can Help Solve Africa's Climate Crisis

has quantified the reduction in health care costs from bad outcomes related to automobile pollution. And they have also quantified the time benefit, finding that the BRT so far has reduced a 90-minute trip... View Details

Keywords: by John Macomber; Green Technology; Energy

01 Feb 2022
What Do You Think?

Is Concierge Management an Answer to the “Big Quit”?

(iStockphoto/Mladen Zivkovic) Several years ago, my spouse and I turned to concierge medicine. We no longer wanted to deal with a US health care system that often provides basically anonymous, production... View Details

Keywords: by James Heskett

2024
Working Paper

Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances

By: Amar Bhidé and Srikant M. Datar

In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details

Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms

SSRN

Read Now

January 2018
Case

Spark Therapeutics: Pioneering Gene Therapy

By: Robert F. Higgins and Tina Liu

Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details

Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy

April 2017
Supplement

Imprimis (C)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel

This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details

Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States

March 2010 (Revised April 2010)
Case

Deworming Kenya: Translating Research into Action (A)

By: Nava Ashraf, Neil Buddy Shah and Rachel Gordon

Karen Levy and her colleague, Margaret Ndanyi, have spent the last six months planning and preparing for a national Kenyan program to target school children most at risk for parasitic worm infection. One week after its launch, the program seemed to be going well but... View Details

Keywords: Planning; Risk and Uncertainty; Mission and Purpose; Performance Efficiency; Programs; Problems and Challenges; Research; Policy; Health Care and Treatment; Management Practices and Processes; Kenya

16 Feb 2016
First Look

February 16, 2016

https://cb.hbsp.harvard.edu/cbmp/product/516027-PDF-ENG Harvard Business School Case 816-060 athenahealth's More Disruption Please Program No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816060-PDF-ENG Harvard Business School Case... View Details

Keywords: Sean Silverthorne

04 Aug 2009
First Look

First Look: August 4

709-474 In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health View Details

Keywords: Martha Lagace

17 Jan 2012
First Look

First Look: January 17

reference points or anchors to simplify the complex tasks of valuation and negotiation. Read the paper: http://people.hbs.edu/mbaker/cv/papers/refpt.pdf The Four Habits of High-Value Health Care... View Details

Keywords: Sean Silverthorne

08 May 2020
In Practice

Nonprofits Hurt by COVID-19 Must Hoard Cash to Hold On

your non-tangible assets to show appreciation, which might be as mundane as providing staff with recreational opportunities to relieve stress. Showing that you care can sometimes make a critical difference in the organization’s ability to... View Details

Keywords: by Danielle Kost

April 2024 (Revised July 2024)
Case

Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs

By: Joseph L. Badaracco, Tom Quinn and John Schultz

Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details

21 Oct 2014
First Look

First Look: October 21

Publisher's link: http://ukcatalogue.oup.com/product/9780198704072.do October 2014 Handbook of Conflict Management Research Reframing Hierarchical Interactions as Negotiations to Promote Change in Health View Details

Keywords: Sean Silverthorne

August 2017 (Revised July 2018)
Case

MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work

By: Elie Ofek and Amanda Dai

In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to... View Details

Keywords: Health Care and Treatment; Product Launch; Product Positioning; Marketing Strategy; Adoption; Pharmaceutical Industry

January 2007 (Revised December 2007)
Case

PSI: Social Marketing Clean Water

By: V. Kasturi Rangan, Nava Ashraf and Marie Bell

Senior management at PSI, arguably the world's largest and most successful social marketer with impressive achievements in the field of family planning, HIV/AIDS, and malaria prevention must determine what to do about their slow-to-take-off clean water initiative.... View Details

Keywords: Investment Funds; Health Care and Treatment; Social Marketing; Natural Environment; Social Enterprise; Business Strategy

July 2000 (Revised November 2001)
Case

Catalyst Medical Solutions

By: Amy C. Edmondson, Richard M.J. Bohmer and Naomi Atkins

Faced with a drop in the NASDAQ, four eHealth entrepreneurs must decide between two distribution strategies for their new company's technology. The team, comprised of three full-time resident physicians and an MBA, has developed software to enable electronic... View Details

Keywords: Product Development; Health Care and Treatment; Distribution; Strategy; Venture Capital; Applications and Software; Partners and Partnerships; Borrowing and Debt; Information Technology Industry; Service Industry